News

Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)

OPT has successfully completed the placement and institutional entitlement offer components of its previously announced capital raisingAs a result of…

1 year ago

Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services

Sales Organization Enhanced, Platform Organization CreatedFREMONT, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell…

1 year ago

Sandoz completes acquisition of leading antifungal agent Mycamine® from Astellas, reinforcing leading global anti-infectives portfolio

Sandoz completes acquisition of worldwide brand rights for Mycamine®(micafungin sodium) from Astellas Leading global echinocandin, one of three major antifungal classes,…

1 year ago

Press Release Biocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders

PRESS RELEASE: 28 August 2023, 7:00 AM CEST Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders Mechelen, Belgium, 28…

1 year ago

Valneva Reports Positive Initial Phase 3 Safety Data in Adolescents for its Single-Shot Chikungunya Vaccine Candidate

Saint-Herblain (France), August 28, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported positive…

1 year ago

DEA Defies President Biden’s Order – Marijuana Researcher Sues DEA For Blocking FDA Clinical Trials

WASHINGTON, DC / ACCESSWIRE / August 28, 2023 / MMJ BioPharma Cultivation, MMJ BioPharma Labs, and MMJ International Holdings are…

1 year ago

Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study

NORTHVALE, NJ / ACCESSWIRE / August 28, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company…

1 year ago

iZafe Group’s CEO Anders Segerström Acquires an Additional 208,333 Shares

STOCKHOLM, SWEDEN / ACCESSWIRE / August 28, 2023 / iZafe Group (STO:IZAFE-B.ST) iZafe Group's CEO, Anders Segerström, has today acquired…

1 year ago

Recent Study from England’s National Health Service Highlights Positive Impact of Implementing HeartFlow’s FFRCT Analysis for Diagnosis of Coronary Artery Disease

Significant reduction in cardiovascular mortality and all-cause mortality for CCTA coupled with FFRCT versus CCTA aloneMOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Two-year results…

1 year ago